Globalhuasca: Reciprocity and Integration of Indigenous and Scientific Worldviews

Even if we don't necessarily share religious, spiritual, or mythological assumptions, are we able to reconcile between such seemingly different and antagonistic worldviews?


Why Psychedelic History Matters

The psychedelic renaissance is afoot, and there’s almost no use arguing with the term anymore. It’s just too catchy.


As legal psychedelic therapy emerges, ethicists urge for more comprehensive frameworks to address sexual abuse

With a checkered history of misconduct, how will psychedelic-assisted therapists be held accountable in the emerging legal field?


Coming Out of the Psychedelic Closet

Who am I? How do you answer that question? I’m a mother, a wife, a teacher, a scholar. And I’m also a psychedelic woman.


We Need to Talk About MAPS Supporting The Police, The Military, and Violent White Supremacism

For decades, MAPS and other proponents of psychedelic medicalization have justified their emphasis on treating police and soldiers as a political strategy in service to mainstreaming psychedelic drugs. This strategy perpetuates the logic of white supremacism, capitalism, and imperialism.


How has Western influence changed the traditional use of iboga in Gabon? | Part 3

The Ibogaine Conversation Part 3 | What is the authentic Bwiti tradition? The answer I got was that this idea of authenticity is an odd idea. It’s a very Western idea. Bwiti considers itself as a culture that’s changing.


We need ecstasy and opioids in place of Prozac and Xanax

Instead of worrying so much about addiction, which tends to correct itself when life becomes tolerable, maybe we should worry more about the sources of emotional suffering.


Christian Angermayer’s ATAI Life Sciences is positioned to take the psychedelic throne from MAPS

After decades of psychedelic nonprofits paving regulatory pathways and priming wealthy investors, for-profits are moving in to reap the rewards.


Want to reduce drug use? Listen to women drug users

The most common consequences of drug policies, whether focusing on the supply or the demand side, bring disproportionate harm to women and girls.


The Future of MDMA: Phase 3 and Beyond

What does the future hold for MDMA? We explore MAPS' ongoing FDA phase 3 clinical trials, rescheduling, health insurance, and expanded access.